This therapeutic drug has the ability to eliminate cancer tumors and offers patients a possibility of recovery without having to undergo heavy and trying surgical interventions.
TL; Dr
A new hope in the world of cancer: the Dostarlimab
The evocation of the word “cancer” often brings up images of hospitals, surgeries and long and exhausting treatments. However, new drug therapy supplied Discreetly institutes a wind of hope in the world of cancer. A hope where the body can restore without heavy surgeries or disabling therapies.
What does this novelty bring concretely?
In a recent study published in the New England Journal of Medicine, a group of 103 cancer patients received a Dostarlimab, an immunotherapy medication, without being surgery. Surprisingly, 82 patients saw their tumors reduce so significantly that surgery was no longer necessary. In another group of 49 patients with rectal cancer, tumors have completely disappeared after six months of Dostarlimab infusions. No operation. No radiation. Just the immune system, strengthened to do what it does best: to retaliate.
The truth behind these figures
It seems too good to be true, but you have to read the details. These remarkable results come from patients whose tumors had a rare genetic abnormality, known as “defect in mesapparious repair” (MMRD). This imperfection makes tumors more vulnerable to the immune system, by making ideal targets for immunotherapy drugs such as Dostarlimab.
Do you like our content?
-Receive our latest publications every day for free and directly in your mailbox
The stories behind science
Take the case of Maureen Sideris, a 71-year-old woman diagnosed with cancer of the gastroesophageal junction. Surgery would have led to months of convalescence, the inability to eat or lie down, and perhaps the temporary loss of its voice. Instead, she chose this experimental program, receiving infusions from Dostarlimab for nine months. His tumor has disappeared. She didn’t need surgery.
More than just medical progress
Cancer treatments are often accompanied by side effects that upset life. This new approach allowed many cancer survivors to find something that they never thought of recovering: normality. It’s not just science – it’s deeply human.
Is this the end of cancer surgeries? Not yet
Although these results seem revolutionary, the experts remain cautious. This is a study carried out in a single center, the Memorial Sloan Kettering. Some patients have not been followed long enough to confirm the lack of recurrence of their cancer. In addition, the study included many types of cancer, each concerning only a few patients. Researchers therefore call for caution before generalizing these results. It’s still early, but incredibly promising.
